Effect of Human Breast Milk on ZO-1 and Occludin Expression in Caco-2 Cells Under Basal Conditions | ||
| Journal of Integrated Maternal and Pediatric Care | ||
| Volume 9, Issue 1, September 2026, Pages 39-45 PDF (530.55 K) | ||
| Document Type: Original Article | ||
| DOI: 10.18502/jimpc.v9i1.22983 | ||
| Authors | ||
| Fatemeh Zaremobini1; Janat Ijabi2, 3; Forough Talebi4; Roghayeh Ijabi* 5; Fereshteh Heshmati6 | ||
| 1Research Center for Nursing and Midwifery Care, Comprehensive Research Institute for Maternal and Child Health, Department of Midwifery, School of Nursing and Midwifery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | ||
| 2Department of Hematology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran | ||
| 3School of Pathology, Faculty of Medicine and Health Sciences, Universiti Sains Malaysia, Kubang Kerian, 15200 Kota Bharu, Kelantan, Malaysia | ||
| 4Department of Midwifery, TeMS.C., Islamic Azad University, Tehran, Iran | ||
| 5Student research committee, School of Nursing and Midwifery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | ||
| 6Department of Midwifery, School of Nursing and Midwifery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | ||
| Abstract | ||
| Background: Necrotizing enterocolitis (NEC) is a serious inflammatory gastrointestinal condition affecting premature infants. Breast milk reduces NEC risk and contains bioactive components that may support intestinal epithelial barrier integrity. This study investigated whether pooled human milk alters the expression of ZO-1 (TJP1) and OCLN in intestinal epithelial cells. Methods: In this in vitro experimental study, Caco-2 cells were treated for 48 hours with 0%, 1%, or 5% (v/v) pooled human milk in low-serum medium (0.5% FBS). Gene expression was assessed by real-time PCR, and protein levels were evaluated by Western blot. Results: No statistically significant changes in ZO-1 or OCLN mRNA or protein levels were de-tected between treated and control groups (P > 0.05). Conclusion: Under these experimental conditions, no statistically significant changes in total ZO-1 or OCLN mRNA or protein levels were detected after 48 hours of treatment with 1% or 5% pooled human milk. These findings do not exclude potential effects on tight-junction localization, assembly, or barrier function. Further studies with larger numbers of independent experiments and functional barrier assessments are warranted. | ||
| Keywords | ||
| Breast milk; Zonula Occludens-1; Tight junctions; Intestinal barrier; Necrotizing enter-ocolitis | ||
| References | ||
|
| ||
|
Statistics Article View: 101 PDF Download: 37 |
||